Undiagnosed and/or untreated Sleep Apnea is a major comorbidity of Cardiovascular Disease and is a significant risk factor for stroke, coronary artery disease, congestive heart failure, and atrial fibrillation. The remedē® System is a breakthrough implantable system that safely and effectively treats moderate to severe central sleep apnea (CSA) in adult patients. CSA is a serious breathing disorder that disrupts the normal breathing pattern during sleep and has been shown to negatively impact the quality of life and heart health.

One attendee will win a WatchPAT® courtesy of Valley Sleep Therapy ($300 Value).

Register for Zoom Webinar